Sodium Fluoride F 18 (Zevacor Pharma, Inc.)
Welcome to the PulseAid listing for the Sodium Fluoride F 18 drug offered from Zevacor Pharma, Inc.. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Zevacor Pharma, Inc. |
NON-PROPRIETARY NAME: | SODIUM FLUORIDE F-18 |
SUBSTANCE NAME: | SODIUM FLUORIDE F-18 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-08 |
END MARKETING DATE: | 0000-00-00 |
Sodium Fluoride F 18 HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Fluoride F 18 from Zevacor Pharma, Inc. |
LABELER NAME: | Zevacor Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mCi/mL) |
START MARKETING DATE: | 2011-12-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49609-102_10b8843a-5f98-4ebf-bb07-239eddbe5d53 |
PRODUCT NDC: | 49609-102 |
APPLICATION NUMBER: | ANDA203592 |
Other SODIUM FLUORIDE F-18 Pharmaceutical Manufacturers / Labelers: